• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Chronic Effects of Antisense Oligodeoxynucleotides Against Angiotensinogen on Cardiac Remodeling in Spontaneously Hypertensive Rats

Research Project

Project/Area Number 10670670
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Circulatory organs internal medicine
Research InstitutionKYUSHU UNIVERSITY

Principal Investigator

MAKINO Naoki  Medical Institute of Bioregulation Kyushu University Professor, 生体防御医学研究所, 教授 (60157170)

Co-Investigator(Kenkyū-buntansha) YANO Kenichi  Medical Institute of Bioregulation Kyushu University Research Associate, 生体防御医学研究所, 助手 (60230281)
安藤 洋志  九州大学, 生体防御医学研究所, 助手 (80301349)
Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥2,800,000 (Direct Cost: ¥2,800,000)
Fiscal Year 1999: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 1998: ¥1,700,000 (Direct Cost: ¥1,700,000)
KeywordsANGIOTENSINOGEN / GENE THERAPY / SHR / HYPERTROPHY
Research Abstract

The angiotensinogen (ATN) is an important determinant for both blood pressure and electrolyte homeostasis. We have already shown that intravenous injection of antisense oligodeoxynucleotides (ODNs) against rat ATN coupled to asialoglycoprotein carrier molecules significantly decreased both the plasma ATN and angiotensin II (Ang. II) contents as well as systolic blood pressure (BP) in spontaneously hypertensive rats (SHR). The present study was therefore examined whether the chronic treatment with this antisense ODNs can affect the cardiac remodeling process in SHRs. The antisense ODNs was intravenously injected to 10-weeks -old SHRs for 10 weeks via their tail veins (A-SHR, n=12) which were compared with SHRs injected with the sense ODNs (S-SHR, n=9) and the untreated SHR (U-SHR, n=9). At the end of those treatment, the both ATN and Ang II concentrations in plasma significantly (p<0.01) decreased in A-SHR (-38%, -58%, respectively) compared with those of S-SHR or U-SHR. The BP in A-SHR … More (168±5.4 mmHg) was significantly reduced (p<0.05) in comparison with those of S-SHR (202±8.4) or SHR (198±7.6), although BP in A-SHR were still higher than that in Wistar Kyoto rats (148±5.3) (p<0.05). The both of the left ventricular (LV) weight and the ratio of LV to body weight also significantly reduced in A-SHR (952±21.2mg, 26.5±0.071mg/g, respectively) compared with S-SHR (1079±32.4, 2.85±0.079) or SHR (1068±39, 2.90±0.080). The Northern blotting showed that the hepatic mRNA expressions for ATN were reduced only in A-SHR, but not in S-SHR or U-SHR. There were no difference in the levels of LV collagen concentration among each SHR group. The mRNA expressions for angiotensin II type 1 receptor (AT1) were more enhanced in LV of A-SHR, but there were no difference in those of angiotensin converting enzyme and type II receptor (AT2) among each SHRs group. These results indicate that the suppression of ATN mRNA can alter the remodeling process in hypertrophy of SHR despite of the partial BP and suggest that the plasma ATN plays a crucial role in the myocyte hypertrophy of LV in SHR, but not in the collagen accumulation of the interstitum. Less

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (19 results)

All Other

All Publications (19 results)

  • [Publications] Otsuka S, Sugano M, Makino N. Sawada S, Hata T, Niho Y.,: "Interaction of mRNAs for Angiotensin II Type 1 and Type 2 Receptors to Vascular Remodelling in Spontaneously Hypertensive Rats."Hypertension. 32. 467-472 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] M, Makino N., Sugano M, Otsuka S, Sawada S: "Secretion of preb HDL increases with the supperssion of cholestery1 ester transfer protein in Hep G2 cells"Atherosclerosis. 146. 291-298 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Makino N, Sugano M, Otsuka S, Sawada S, Hata T.: "Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats."Cardiovasc Res. 44. 543-548 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Sugano M, Sawada S, Tsuchida K, Makino N, Kamada M: "Low density lipoproteins develop resistance to oxidative modification due to inhibition of cholestery1 ester transfer protein by a monoclonal antibody."J. Lipid Res. 41. 126-133 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Otsuka S, Sugano M, Makino N, Sawada S, Hata T, Niho Y.: "Interaction of mRNAs for Angiotensin II Type 1 and Type 2 Receptors to Vascular Remodeling in Spontaneously Hypertensive Rats."Hypertension.. 32. 467-472 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Makino N, Sugano S, Otsuka S, Sawada S.: "Intravenous Injection with antisense Oligodeoxynucleo-tides against Angiotensinogen decreases blood pressure in spontaneously hypertensive rats"Hypertension.. 31. 1166-1170 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Sawada S, Sugano M, Makino N, Okamoto H, Tsuchida K.: "Secretion of preb HDL increases with the suppression of cholesteryl ester transfer protein in Hep G2 cells."Atherosclerosis.. 146. 291-298 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Masumoto K, Makino N, Sugano M, Miyamoto S, Hata T, Yanaga T.: "Extracellular matrix regulation in the development of Syrian cardiomyopathic Bio 4.6 and Bio 53.58 hamsters."J Mol Cell Cardiol.. 31. 1607-1615 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Makino N, Sugano M, Otsuka S, Sawada S, Hata T.: "Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats."Cardiovasc Res. 44. 543-548 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Tanaka, F., Mori, M., Haraguchi, M., Makino, N., Yoshikawa, Y., Akiyoshi, T.: "Coexisting extraaderenal pheochromocytoma and vonMeyenberg complexes : Report of a case."Jap J Surg. 29. 80-82 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Yano, K., Makino, N., Hirayama, H., Hatakenaka, M., Matsui, H., Soeda, T., Hamada, T.: "Panetrating atherosclerotic ulcer at the proximal aorta complicated with cardiac temponade and aortic valvre regurgitation."Jap Circ. Journal.. 63. 228-230 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Sugano M, Sawada S, Tsuchida K, Makino N, Kamada M.: "Low density lipoproteins develop resistance to oxidative modification due to inhibition of cholesteryl ester transfer protein by a monoclonal antibody."J. Lipid Res.. 41. 126-133 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Sawada S,Sugano M,Makino N,Okamoto H,Tsuchida K.: "Secretion of preb HDL increases with the suppression of cholesteryl ester transfer protein in Hep G2 cells"Atherosclerosis. 146. 291-298 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Masutomo K,Makino N,Sugano M,Mityamoto S,Hata T,Yanaga T.: "Extracellular matrix regulation in the development of Syrian cardiomyopathic Bio4.6 and Bio 53.58 hamsters"J Mol Cell Cardiol. 31. 1607-1615 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Makino N,Sugano M,Otsuka S,Sawada S,Hata T.: "Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats"Cardiovasc Rec. 44. 543-548 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Sugano M,Sawada S,Tsuchida K,Makino N,Kamada M: "Low density lipoproteins develop resistance to oxidative modification due to inhibition of cholesteryl ester transfer protein by a monoclonal antibody"J. Lipid Res. 41. 126-133 (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Otsuka S, Sugano M, Makino N, Sawada S, Hata T, Niho Y: "Interaction of mRNAs for Angiotensin II Type 1 and Type 2 Receptors to Vascular Remodelling in Spontaneously Hypertensive Rats" Hypertension. 32. 467-472 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Sugano M, Makino N, Sawada S, Otsuka S, Watanabe M, Okamoto H, Kamada M, Mizushima A: "Effect of Antisense Oigodeoxynud eatides against Chalesteryl Ester Transfer Protein the Development of Ather oscler osisin Chalester-fed Rabbits" J. Biel. Chem.273. 5033-5036 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Makino N, Sugano M, Otsuka S Sawada S: "Intravenous Injection with antisense Oligodeoxynucleo-tides against Angiotensinogen decreases blood pessure in spontaneously hypertensivr rats" Hypertension. 31. 1166-1170 (1998)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi